HCM
MEDP icon

Highbridge Capital Management’s Medpace MEDP Stock Holding History

Highbridge Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,872
Closed -$596K – 731
2018
Q2 		$596K Buy
+13,872
New +$560K 0.01% 555
2017
Q3 		– Sell
-8,623
Closed -$250K – 1687
2017
Q2 		$250K Buy
+8,623
New +$242K ﹤0.01% 1027

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highbridge Capital Management's MEDP Position: Q3 2018 in Review

Highbridge Capital Management sold out of Medpace (MEDP) in Q3 2018, closing a stake of 13,872 shares — an estimated $596K sold.

Highbridge Capital Management first reported a position in MEDP in Q2 2017 and held it in 2 quarters. The position peaked at $596K in Q2 2018. 207 funds tracked by Wall St. Rank hold MEDP as of Q3 2018.

  • Highbridge Capital Management reported no remaining Medpace position as of Q3 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 13,872 Medpace shares in Q3 2018, an estimated $596K.
  • Highbridge Capital Management first reported a position in Medpace in Q2 2017 and held it in 2 quarters.
  • Highbridge Capital Management's Medpace position peaked at $596K in Q2 2018.
  • 207 funds tracked by Wall St. Rank held Medpace as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.